Peptides - Compound guides
Selank
Selank is a synthetic peptide based on the immune molecule tuftsin, developed and registered in Russia but not approved as a medicine in the UK, EU or US.
Selank is a short synthetic peptide derived from tuftsin, a naturally occurring four-amino-acid fragment of the immunoglobulin G antibody molecule. Tuftsin was identified in the 1970s at Tufts University, which is where its name comes from, and was studied as a signalling molecule involved in immune function. Selank takes that sequence and attaches a short additional chain of amino acids, the same structural trick used with Semax, to slow enzymatic breakdown and extend how long the molecule survives in the body.
Like Semax, Selank came out of the same Russian research environment and is registered in Russia as an anxiolytic - a class of medicine intended to reduce anxiety. It has no marketing authorisation in the United Kingdom, the European Union or the United States. Online it is frequently promoted as a gentle, side-effect-free alternative to prescribed anxiety medicines, a claim that is not supported by anything resembling the evidence base those medicines had to produce. This lesson explains what is actually known and, more importantly, what is not.
How it is thought to work
The mechanisms described here are proposed rather than demonstrated. They are drawn largely from animal and laboratory work and should not be taken as evidence of any effect in people.
Because Selank is a tuftsin analogue, the first proposed mechanism is immune signalling. Tuftsin itself influences immune cell behaviour, and laboratory studies have reported that Selank affects the balance of cytokines, the messenger proteins immune cells use to communicate. Since immune signalling and brain signalling are known to interact, some researchers have suggested this is one route by which the compound might act centrally, though this remains a hypothesis rather than a mapped pathway.
The second and more commonly cited proposal involves the GABA system. GABA is the brain's main inhibitory neurotransmitter - broadly, the signal that dampens neuronal activity - and it is the system established sedative medicines act on. Animal work has reported that Selank influences GABAergic signalling, though apparently not by binding the same receptor site those medicines use. Related research has reported effects on the enzymes that break down enkephalins, one of the body's own peptide families, and on monoamine turnover. All of these are observations in animals and cells. Translating "affects GABAergic signalling in a rodent" into any statement about how a person feels is a leap the evidence does not license.
What the research actually shows
Selank sits at an early-human stage of evidence and carries the same structural weaknesses as Semax. Published human studies exist, some comparing Selank against established medicines. But the literature is old, the trials are small, they emerge overwhelmingly from a single national research tradition, and much of it appears in Russian-language journals that Western systematic reviewers rarely capture. Where trial reports do exist, the methodological detail needed to judge them - randomisation procedure, blinding integrity, pre-registered outcomes, handling of dropouts - is often thin or unavailable.
Why does independent replication carry so much weight here? Because anxiety outcomes are exactly the kind of endpoint where bias does the most damage. They are measured by subjective rating scales, they respond strongly to placebo, and they fluctuate naturally over the weeks a trial runs, so a small unblinded study will very often produce an encouraging-looking result regardless of what the participant received. The only reliable defence is a large, properly blinded trial run by people with no investment in the outcome, ideally more than once and in more than one country. That defence has not been mounted for Selank. The result is not a compound proven ineffective - it is a compound about which the honest answer to "does it work?" is that nobody has done the work required to know.
Where the evidence stops
- No large, independent, placebo-controlled trials to modern Western regulatory standards have been published.
- Human data comes almost entirely from one research tradition, in a language and set of journals poorly covered by international reviews.
- The proposed mechanism is inferred from animal and cell studies; how it behaves in the human brain is not established.
- Long-term safety, tolerance and effects on stopping have not been characterised in healthy people.
- Interactions with prescribed psychiatric medicines are unstudied, which matters because those medicines act on overlapping systems.
- Unregulated material offers no assurance of identity, purity or sterility.
Legal and regulatory status
Selank is not an approved medicine in the UK. It has no MHRA marketing authorisation and no approval in the EU or US. It is registered as a medicine in Russia and some neighbouring countries. That registration is not equivalent to UK, EU or US approval and does not imply an equivalent evidence review has taken place - regulators differ in the trial designs they demand, the standard of proof they apply, and the manufacturing inspections they carry out. Treating a Russian registration as a proxy for MHRA approval is a category error, and one online sellers make constantly.
Material available in the UK is generally sold labelled "research use only", which means it is not approved for human use and is not made to medicines-grade quality standards. There is no independent verification that the contents match the label.
This lesson is educational content only and is not medical advice. Selank is not an approved medicine in the UK and nothing here is a recommendation to use it. Anxiety and mental health are serious matters, and decisions about them belong with a qualified healthcare professional.
Neuro and sleep compounds
Start with the overview: How research peptides are grouped into families
Further reading
Sources for this classroom
Educational content only. Not medical advice, diagnosis or treatment. Always consult a qualified healthcare professional before changing your health regimen.
